Richard G. Vincent

Insider Reports History

Entity
Individual
Location
C/O Women First Health Care, 5355 Mira Sorrento Place Ste. 700, San Diego, CA
Signature
/s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard G. Vincent:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Oncternal Therapeutics, Inc. Chief Financial Officer Common Stock 141K $69.9K $0.50 Jan 3, 2024 Direct
Oncternal Therapeutics, Inc. Chief Financial Officer Common Stock 4.53K $2.25K $0.50 Jan 3, 2024 By Family Trust
Oncternal Therapeutics, Inc. Chief Financial Officer Common Stock 1.83K $910 $0.50 Jan 3, 2024 By Child
Oncternal Therapeutics, Inc. Chief Financial Officer Stock Option 14.2K Feb 14, 2024 Direct
Forte Biosciences, Inc. Director Stock Option (right to buy) 2K Sep 17, 2024 Direct

Insider Reports Filed by Richard G. Vincent

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FBRX Forte Biosciences, Inc. Sep 17, 2024 1 $0 4 Sep 19, 2024 Director
FBRX Forte Biosciences, Inc. Sep 17, 2024 0 $0 3 Sep 19, 2024 Director
ONCT Oncternal Therapeutics, Inc. Feb 14, 2024 1 $0 4 Feb 15, 2024 Chief Financial Officer
ONCT Oncternal Therapeutics, Inc. Jan 3, 2024 1 -$4.4K 4 Jan 5, 2024 Chief Financial Officer
ONCT Oncternal Therapeutics, Inc. Oct 2, 2023 12 $0 4 Oct 4, 2023 Chief Financial Officer
ONCT Oncternal Therapeutics, Inc. Jul 3, 2023 1 -$2.54K 4 Jul 5, 2023 Chief Financial Officer
ONCT Oncternal Therapeutics, Inc. Apr 13, 2023 1 $8.96K 4 Apr 14, 2023 Chief Financial Officer
ONCT Oncternal Therapeutics, Inc. Feb 21, 2023 1 $0 4 Feb 23, 2023 Chief Financial Officer
ONCT Oncternal Therapeutics, Inc. Jan 3, 2023 1 -$4.52K 4 Jan 5, 2023 Chief Financial Officer
ONCT Oncternal Therapeutics, Inc. Jul 28, 2022 2 $0 4 Aug 1, 2022 Chief Financial Officer
ONCT Oncternal Therapeutics, Inc. Mar 24, 2022 5 $7.21K 4 Mar 28, 2022 Chief Financial Officer
ONCT Oncternal Therapeutics, Inc. Jan 27, 2022 3 $21.6K 4 Jan 31, 2022 Chief Financial Officer
ONCT Oncternal Therapeutics, Inc. Jan 20, 2022 1 $0 4 Jan 24, 2022 Chief Financial Officer
ONCT Oncternal Therapeutics, Inc. Jan 3, 2022 1 $0 4 Jan 5, 2022 Chief Financial Officer